Bronchopulmonary Dysplasia Drug Market Trends, Opportunities & Competitive Landscape
The Bronchopulmonary Dysplasia Drug Market is moving toward more targeted and personalized treatment strategies as researchers improve their understanding of neonatal respiratory disease. With the market expected to reach USD 3.5 billion by 2035 at a 5.4% CAGR, personalized medicine and data-driven drug development are becoming important areas of opportunity. BPD primarily affects vulnerable...
0 Comments 0 Shares 85 Views 0 Reviews